These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32147519)

  • 1. Radiation-Induced Lymphopenia Predicts Poorer Prognosis in Patients With Breast Cancer: A Post Hoc Analysis of a Randomized Controlled Trial of Postmastectomy Hypofractionated Radiation Therapy.
    Sun GY; Wang SL; Song YW; Jin J; Wang WH; Liu YP; Ren H; Fang H; Tang Y; Zhao XR; Song YC; Yu ZH; Liu XF; Li YX
    Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):277-285. PubMed ID: 32147519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of lymphocytes in patients with breast cancer receiving radiotherapy after breast-conserving surgery: A post hoc analysis of a phase III randomized trial.
    Song YC; Chen SY; Zhao XR; Jing H; Fang H; Tang Y; Hu SY; Song YW; Jin J; Liu YP; Qi SN; Sun GY; Zhong QZ; Du XH; Liu J; Li YX; Wang SL
    Radiother Oncol; 2024 Oct; 199():110390. PubMed ID: 38897316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China.
    Wang SL; Fang H; Hu C; Song YW; Wang WH; Jin J; Liu YP; Ren H; Liu J; Li GF; Du XH; Tang Y; Jing H; Ma YC; Huang Z; Chen B; Tang Y; Li N; Lu NN; Qi SN; Yang Y; Sun GY; Liu XF; Li YX
    J Clin Oncol; 2020 Nov; 38(31):3604-3614. PubMed ID: 32780661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer.
    Tovanabutra C; Katanyoo K; Uber P; Chomprasert K; Sukauichai S
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):119-125. PubMed ID: 31983173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative retrospective analysis of locoregional recurrence in unselected breast cancer patients treated with conventional versus hypofractionated radiotherapy at a tertiary cancer center?
    Yadav R; Lal P; Agarwal S; Misra S; Verma M; Das KJM; Senthil Kumar SK; Kumar A; Mishra SK; Agarwal A; Agarwal G; Mishra A; Chand G; Verma AK; Kumar S
    J Cancer Res Ther; 2020; 16(6):1314-1322. PubMed ID: 33342790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer.
    Yang J; Qi SN; Fang H; Song YW; Jin J; Liu YP; Wang WH; Yang Y; Tang Y; Ren H; Chen B; Lu NN; Tang Y; Li N; Jing H; Wang SL; Li YX
    Breast; 2021 Aug; 58():72-79. PubMed ID: 33933925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes of the CHIRP Trial: A Phase II Prospective Randomized Trial of Conventionally Fractionated Versus Moderately Hypofractionated Prostate and Pelvic Nodal Radiation Therapy in Patients With High-Risk Prostate Cancer.
    Wang MH; Vos LJ; Yee D; Patel S; Pervez N; Parliament M; Usmani N; Danielson B; Amanie J; Pearcey R; Ghosh S; Field C; Fallone BG; Murtha AD
    Pract Radiat Oncol; 2021; 11(5):384-393. PubMed ID: 33705985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is There a Role for Hypofractionated Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis.
    Zayed S; Chen H; Ali E; Rodrigues GB; Warner A; Palma DA; Louie AV
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):575-586. PubMed ID: 32544575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Outcomes of Post-mastectomy Breast Cancer Patients Treated with Hypofractionated Radiation Treatment Compared to Conventional Fractionation -a Retrospective Cohort Study.
    Raveendran C; Meloot SS; Yadev I
    Gulf J Oncolog; 2023 May; 1(42):26-34. PubMed ID: 37283257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
    Wang SL; Fang H; Song YW; Wang WH; Hu C; Liu YP; Jin J; Liu XF; Yu ZH; Ren H; Li N; Lu NN; Tang Y; Tang Y; Qi SN; Sun GY; Peng R; Li S; Chen B; Yang Y; Li YX
    Lancet Oncol; 2019 Mar; 20(3):352-360. PubMed ID: 30711522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy.
    Iocolano M; Wild AT; Hannum M; Zhang Z; Simone CB; Gelblum D; Wu AJ; Rimner A; Shepherd AF
    Acta Oncol; 2020 Feb; 59(2):164-170. PubMed ID: 31608751
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison  of  efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma.
    Lyu J; Liu T; Li T; Li F; Wang Q; Wang J; Han Y; Wang J; Zhang J; Peng L; Lang J
    Cancer Med; 2019 Jul; 8(8):3710-3718. PubMed ID: 31119872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated radiation treatment following mastectomy in early breast cancer: the Christchurch experience.
    Ko DH; Norriss A; Harrington CR; Robinson BA; James ML
    J Med Imaging Radiat Oncol; 2015 Apr; 59(2):243-7. PubMed ID: 25287654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two hypofractionated radiotherapy schedules in locally advanced postmastectomy breast cancer patients.
    Choudhary S; Gupta N; Misra S; Munnee NN; Kumar A; Ranjan R; Dhar SS; Kumar D; Mourya A; Aggarwal LM
    J Cancer Res Ther; 2020; 16(6):1331-1335. PubMed ID: 33342792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions.
    Jiang H; Meng L; Zhang H; Dai X; Zhang Q; Ju Z; Yu W; Ma L
    BMC Cancer; 2021 Dec; 21(1):1284. PubMed ID: 34852776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis of phase III randomized trials.
    Lehrer EJ; Kishan AU; Yu JB; Trifiletti DM; Showalter TN; Ellis R; Zaorsky NG
    Radiother Oncol; 2020 Jul; 148():235-242. PubMed ID: 32505965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization and Survival Impact of Hypofractionated Radiotherapy in Stage I Non-small Cell Lung Cancer.
    Saeed NA; Jin L; Amini A; Verma V; Lester-Coll NH; Chen PH; Decker RH; Park HS
    Am J Clin Oncol; 2023 Feb; 46(2):66-72. PubMed ID: 36662872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancer.
    Wu G; Baine MJ; Zhao N; Li S; Li X; Lin C
    BMC Cancer; 2019 Oct; 19(1):977. PubMed ID: 31640607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated radiation leads to more rapid bleeding cessation in women with vaginal bleeding secondary to gynecologic malignancy.
    Moradi LA; Schneider CS; Deshane AS; Popple RA; Kim RY; Marcrom SR
    Radiat Oncol; 2022 Feb; 17(1):34. PubMed ID: 35164826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischaemic heart disease following conventional and hypofractionated radiation treatment in a contemporary breast cancer series.
    James M; Swadi S; Yi M; Johansson L; Robinson B; Dixit A
    J Med Imaging Radiat Oncol; 2018 Jun; 62(3):425-431. PubMed ID: 29436171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.